<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="publisher">pmed</journal-id><journal-id journal-id-type="allenpress-id">plme</journal-id><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="pmc">plosmed</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Medicine</journal-title></journal-title-group><issn pub-type="ppub">1549-1277</issn><issn pub-type="epub">1549-1676</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="doi">10.1371/journal.pmed.0050195</article-id><article-id pub-id-type="publisher-id">08-PLME-CN-2250</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Correction</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Infectious Diseases/HIV Infection and AIDS</subject>
          <subject>Public Health and Epidemiology</subject>
          <subject>Evidence-Based Healthcare</subject>
        </subj-group>
      </article-categories><title-group><article-title>Correction: Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared</article-title><alt-title alt-title-type="running-head">Correction</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Keiser</surname>
            <given-names>Olivia</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Orrell</surname>
            <given-names>Catherine</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Egger</surname>
            <given-names>Matthias</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wood</surname>
            <given-names>Robin</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Brinkhof</surname>
            <given-names>Martin W. G</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Furrer</surname>
            <given-names>Hansjakob</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>van Cutsem</surname>
            <given-names>Gilles</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Ledergerber</surname>
            <given-names>Bruno</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Boulle</surname>
            <given-names>Andrew</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <collab xlink:type="simple">for the Swiss HIV Cohort Study (SHCS) and the International Epidemiologic Databases to Evaluate AIDS in Southern Africa (IeDEA-SA)</collab>
        </contrib>
      </contrib-group><pub-date pub-type="ppub">
        <month>9</month>
        <year>2008</year>
      </pub-date><pub-date pub-type="epub">
        <day>30</day>
        <month>9</month>
        <year>2008</year>
      </pub-date><volume>5</volume><issue>9</issue><elocation-id>e195</elocation-id><history>
        <date date-type="received">
          <day>13</day>
          <month>8</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>8</month>
          <year>2008</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2008</copyright-year><copyright-holder> Keiser et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article ext-link-type="doi" id="RA1" issue="7" page="e148" related-article-type="corrected-article" vol="5" xlink:href="info:doi/10.1371/journal.pmed.0050148" xlink:title="Research Article" xlink:type="simple">
				<article-title>Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared</article-title>
			</related-article><counts>
        <page-count count="1"/>
      </counts><!--===== Restructure custom-meta-wrap to custom-meta-group =====--><custom-meta-group>
        <custom-meta>
          <meta-name>citation</meta-name>
          <meta-value>Keiser O, Orrell C, Egger M, Wood R, Brinkhof MWG, et al. (2008) Correction: Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared. PLoS Med 5(9): e195. doi:<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0050195" xlink:type="simple">10.1371/journal.pmed.0050195</ext-link></meta-value>
        </custom-meta>
      </custom-meta-group></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title/>
      <p>Correction for:</p>
      <p>Keiser O, Orrell C, Egger M, Wood R, Brinkhof MWG, et al. (2008) Public-health and individual approaches to antiretroviral therapy: Township South Africa and Switzerland compared. PLoS Med 5(7): e148. doi:<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0050148" xlink:type="simple">10.1371/journal.pmed.0050148</ext-link></p>
      <p>The <xref ref-type="table" rid="pmed-0050195-t001">Table 1</xref> originally published with this manuscript stated that 95.1% of the patients from South Africa used regimens recommended by guidelines, compared to 99.6% in the Swiss cohort. This is incorrect: the figures have been reversed. As the article text makes clear, 95.1% of the Swiss patients used regimens recommended by guidelines, compared to 99.6% in the South African cohorts.</p>
      <table-wrap content-type="4col" id="pmed-0050195-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.0050195.t001</object-id><label>Table 1</label><caption>
          <title>Baseline Characteristics of Patients Starting HAART in Khayelitsha and Gugulethu, South Africa and the Swiss HIV Cohort Study</title>
        </caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.0050195.t001" xlink:type="simple"/><!-- <table frame="hsides" rules="groups"> <colgroup> <col id="tb1col1" align="left"/> <col id="tb1col2" align="left"/> <col id="tb1col3" align="left"/> <col id="tb1col4" align="left"/> </colgroup> <thead> <tr> <td><bold>Category</bold></td> <td><bold>Subcategory</bold></td> <td><bold>South African Cohorts</bold></td> <td><bold>Swiss HIV Cohort</bold></td> </tr> </thead> <tbody> <tr> <td>Patients, <italic>n</italic></td> <td>&mdash;</td> <td>2,348</td> <td>1,016</td> </tr> <tr> <td>&nbsp;</td> <td>Females, <italic>n</italic> (&percnt;)</td> <td>1,663 (71&percnt;)</td> <td>333 (33&percnt;)</td> </tr> <tr> <td>Age, y, median (IQR)</td> <td>&mdash;</td> <td>32.7 (28.5&ndash;38.2)</td> <td>38.3 (31.7&ndash;46.1)</td> </tr> <tr> <td>CD4 cell count, cells/&mu;l, median (IQR)</td> <td>&mdash;</td> <td>80 (30&ndash;138)</td> <td>204 (122&ndash;291)</td> </tr> <tr> <td>CD4 cell count, number missing (&percnt;)</td> <td>&mdash;</td> <td>123 (5.2&percnt;)</td> <td>50 (4.9&percnt;)</td> </tr> <tr> <td>HIV-1 viral load, log<sub>10 </sub> copies/ml, median (IQR)</td> <td>&mdash;</td> <td>5.1 (4.6&ndash;5.5)</td> <td>5.0 (4.5&ndash;5.5)</td> </tr> <tr> <td>HIV-1 viral load, number missing (&percnt;)</td> <td>&mdash;</td> <td>288 (12.3&percnt;)</td> <td>53 (5.2&percnt;)</td> </tr> <tr> <td>Clinical stage: CDC stage C, WHO stage III/IV, <italic>n</italic> (&percnt;)</td> <td>&mdash;</td> <td>2,126 (90.6&percnt;)</td> <td>188 (18.5&percnt;)</td> </tr> <tr> <td>Duration of follow-up (years)<xref ref-type="fn" rid="nt101"><sup>a</sup></xref>, median (IQR)</td> <td>&mdash;</td> <td>0.9 (0.5&ndash;1.5)</td> <td>2.0 (1.1&ndash;2.0)</td> </tr> <tr> <td>Number of patients starting HAART in year, <italic>n</italic> (&percnt;)</td> <td>2001</td> <td>79 (3.4&percnt;)</td> <td>179 (17.6&percnt;)</td> </tr> <tr> <td>&nbsp;</td> <td>2002</td> <td>246 (10.5&percnt;)</td> <td>204 (20.1&percnt;)</td> </tr> <tr> <td>&nbsp;</td> <td>2003</td> <td>509 (21.7&percnt;)</td> <td>185 (18.2&percnt;)</td> </tr> <tr> <td>&nbsp;</td> <td>2004&ndash;2006<xref ref-type="fn" rid="nt102"><sup>b</sup></xref></td> <td>1,514 (64.5&percnt;)</td> <td>448 (44.1&percnt;)</td> </tr> <tr> <td>Initial HAART regimen, <italic>n</italic> (&percnt;)</td> <td>2 NRTIs &plus; 1 NNRTI</td> <td>2,339 (99.7&percnt;)</td> <td>470 (46.3&percnt;)</td> </tr> <tr> <td>&nbsp;</td> <td>2 NRTIs &plus; 1 PI</td> <td>9 (0.4&percnt;)</td> <td>449 (44.2&percnt;)</td> </tr> <tr> <td>&nbsp;</td> <td>Other</td> <td>0</td> <td>97 (9.6&percnt;)</td> </tr> <tr> <td>Four most commonly used initial HAART regimens, <italic>n</italic> (&percnt;)</td> <td>3TC D4T EFV</td> <td>918 (39.1&percnt;)</td> <td>&mdash;</td> </tr> <tr> <td>&nbsp;</td> <td>3TC D4T NVP</td> <td>780 (33.2&percnt;)</td> <td>&mdash;</td> </tr> <tr> <td>&nbsp;</td> <td>3TC AZT EFV</td> <td>425 (18.1&percnt;)</td> <td>&mdash;</td> </tr> <tr> <td>&nbsp;</td> <td>3TC AZT NVP</td> <td>216 (9.2&percnt;)</td> <td>&mdash;</td> </tr> <tr> <td>&nbsp;</td> <td>3TC AZT EFV</td> <td>&mdash;</td> <td>304 (29.9&percnt;)</td> </tr> <tr> <td>&nbsp;</td> <td>3TC AZT LPV/r</td> <td>&mdash;</td> <td>202 (19.9&percnt;)</td> </tr> <tr> <td>&nbsp;</td> <td>3TC AZT NFV</td> <td>&mdash;</td> <td>99 (9.7&percnt;)</td> </tr> <tr> <td>&nbsp;</td> <td>3TC TNV EFV</td> <td>&mdash;</td> <td>65 (6.4&percnt;)</td> </tr> <tr> <td>Initial HAART regimens used to treat 95&percnt; of patients, <italic>n</italic></td> <td>&mdash;</td> <td>4</td> <td>36</td> </tr> <tr> <td>Patients using initial HAART regimens recommended by guidelines, &percnt;</td> <td>&mdash;</td> <td>99.6</td> <td>95.1</td> </tr> </tbody> </table> --><!-- <table-wrap-foot> <fn id="nt101"><p><sup>a</sup>Censored after 2 y.</p></fn> <fn id="nt102"><p><sup>b</sup>Recruitment not completed for the years 2005/06.</p></fn> </table-wrap-foot> --></table-wrap>
      <p>A corrected version of <xref ref-type="table" rid="pmed-0050195-t001">Table 1</xref> is published here.</p>
    </sec>
  </body>
</article>